{"id":395812,"date":"2020-12-08T16:08:09","date_gmt":"2020-12-08T21:08:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=395812"},"modified":"2020-12-08T16:08:09","modified_gmt":"2020-12-08T21:08:09","slug":"timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/","title":{"rendered":"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference"},"content":{"rendered":"
\n

\n Presentation on Tuesday December 15th<\/sup>\u00a0\u00a0at 10:40am EST<\/em>
\n \n <\/p>\n

LOS ANGELES, CA, Dec. 08, 2020 (GLOBE NEWSWIRE) — via NewMediaWire<\/a>\u00a0<\/u>— Timber Pharmaceuticals, Inc. (“Timber” or the \u201cCompany\u201d) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announcedthat it will be presenting at the 13th annual LD Micro Main Event investor conference on Tuesday, December 15, 2020 at 10:40 AM EST \/ 7:40 AM PST. John Koconis, Chief Executive Officer of Timber Pharma, will be presenting to a live, virtual audience.\u00a0<\/p>\n

\n Register here:\u00a0<\/strong>
\n
\n
\n ve.mysequire.com\/<\/u>
\n <\/strong>
\n <\/a>\n <\/p>\n

The Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts.\u00a0<\/p>\n

“The time has finally come to do something different in the virtual conference world. Let\u2019s see if we can pull off something that can be enjoyed by both executives and investors alike,\u201d stated Chris Lahiji, Founder of LD, now a wholly owned subsidiary of SRAX, Inc.<\/p>\n

The Main Event will take place on December 14th and 15th, exclusively on the Sequire Virtual Events platform.\u00a0<\/p>\n

\n View Timber Pharmaceuticals profile here: http:\/\/www.ldmicro.com\/profile\/TMBR<\/strong>\n <\/p>\n

\n Profiles powered\u00a0<\/strong>
\n
\n
\n by\u00a0LD Micro<\/u>
\n <\/strong>
\n <\/a>\n <\/p>\n

\n About Timber Pharmaceuticals, Inc.<\/strong>\n <\/p>\n

Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases. The Company’s investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. The Company is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), facial angiofibromas (FAs) in tuberous sclerosis complex (TSC), and localized scleroderma. For more information, visit\u00a0www.timberpharma.com<\/u><\/a>.<\/p>\n

\n About LD Micro\/SEQUIRE<\/strong>\n <\/p>\n

LD Micro began in 2006 with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. For more information, please visit\u00a0ldmicro.com<\/u><\/a>.<\/p>\n

The upcoming Main Event will be highlighting a new format that will benefit both executives and the investors tuning in from all over the globe.\u00a0<\/p>\n

In September 2020, LD Micro. Inc. was acquired by SRAX, Inc.,\u00a0a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform,\u00a0Sequire<\/u><\/strong><\/a>, companies can track their investors\u2019 behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit\u00a0srax.com\u00a0<\/u><\/strong><\/a>and\u00a0mysequire.com<\/u><\/strong><\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company’s product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management’s current beliefs and assumptions.<\/p>\n

These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential, “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company’s Form 10-Q filed on August 18, 2020 and its other filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.<\/p>\n

\n For more information, contact:<\/strong>\n <\/p>\n

Timber Pharmaceuticals, Inc.\u00a0<\/p>\n

John Koconis\u00a0<\/p>\n

Chief Executive Officer<\/p>\n

\n jkoconis@timberpharma.com<\/a>\n <\/p>\n

\n \n <\/p>\n

Investor Relations:<\/p>\n

Stephanie Prince<\/p>\n

PCG Advisory<\/p>\n

(646) 762-4518<\/p>\n

\n sprince@pcgadvisory.com<\/a>\n <\/p>\n

\n \n <\/p>\n

Media Relations:\u00a0<\/p>\n

Adam Daley<\/p>\n

Berry & Company Public Relations\u00a0<\/p>\n

(212) 253-8881<\/p>\n

\n adaley@berrypr.com<\/a>\n <\/p>\n

\n \n <\/p>\n

\n Source:<\/strong>Timber Pharmaceuticals via LD Micro\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Presentation on Tuesday December 15th\u00a0\u00a0at 10:40am EST LOS ANGELES, CA, Dec. 08, 2020 (GLOBE NEWSWIRE) — via NewMediaWire\u00a0— Timber Pharmaceuticals, Inc. (“Timber” or the \u201cCompany\u201d) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announcedthat it will be presenting at the 13th annual LD Micro Main Event investor conference on Tuesday, December 15, 2020 at 10:40 AM EST \/ 7:40 AM PST. John Koconis, Chief Executive Officer of Timber Pharma, will be presenting to a live, virtual audience.\u00a0 Register here:\u00a0 ve.mysequire.com\/ The Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors … <\/p>\n

Continue reading “Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-395812","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTimber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Presentation on Tuesday December 15th\u00a0\u00a0at 10:40am EST LOS ANGELES, CA, Dec. 08, 2020 (GLOBE NEWSWIRE) — via NewMediaWire\u00a0— Timber Pharmaceuticals, Inc. (“Timber” or the \u201cCompany\u201d) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announcedthat it will be presenting at the 13th annual LD Micro Main Event investor conference on Tuesday, December 15, 2020 at 10:40 AM EST \/ 7:40 AM PST. John Koconis, Chief Executive Officer of Timber Pharma, will be presenting to a live, virtual audience.\u00a0 Register here:\u00a0 ve.mysequire.com\/ The Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors … Continue reading "Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-08T21:08:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference\",\"datePublished\":\"2020-12-08T21:08:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/\"},\"wordCount\":727,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/\",\"name\":\"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw==\",\"datePublished\":\"2020-12-08T21:08:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/","og_locale":"en_US","og_type":"article","og_title":"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference - Market Newsdesk","og_description":"Presentation on Tuesday December 15th\u00a0\u00a0at 10:40am EST LOS ANGELES, CA, Dec. 08, 2020 (GLOBE NEWSWIRE) — via NewMediaWire\u00a0— Timber Pharmaceuticals, Inc. (“Timber” or the \u201cCompany\u201d) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announcedthat it will be presenting at the 13th annual LD Micro Main Event investor conference on Tuesday, December 15, 2020 at 10:40 AM EST \/ 7:40 AM PST. John Koconis, Chief Executive Officer of Timber Pharma, will be presenting to a live, virtual audience.\u00a0 Register here:\u00a0 ve.mysequire.com\/ The Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors … Continue reading \"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-08T21:08:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference","datePublished":"2020-12-08T21:08:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/"},"wordCount":727,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/","name":"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw==","datePublished":"2020-12-08T21:08:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODgzNSMzODYyMTMzIzUwMDA3MjA3Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/timber-pharmaceuticals-to-present-at-the-13th-annual-ld-micro-main-event-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=395812"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395812\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=395812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=395812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=395812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}